The Finance and Accounting for Bioscience Companies event, held on September 18-19, 2024, at the Omni Boston Hotel at the Seaport in Boston, MA, provided a comprehensive overview of strategies employed by innovative bioscience companies to scale and grow within their unique industry. The agenda covered various crucial aspects, including funding arrangements aligned with the prevailing market environment, financial preparations essential for a successful commercialization launch, and considerations for team structure and management in the context of partnerships and collaborations.
A notable focus of the event was on digital transformation within the bioscience sector. Participants were treated to insights into automating workflows for optimal efficiencies within accounting and finance teams. Discussions extended to pricing and contracting strategies for digitization, streamlining the partner journey, and careful considerations for incorporating artificial intelligence (AI) while maintaining compliance with industry standards.
Operational excellence took center stage, with a particular emphasis on technical accounting best practices from regulatory, documentation, and disclosure perspectives. Attendees benefitted from in-depth discussions on forecasting and analysis approaches, offering valuable insights for planning accuracy in the dynamic bioscience landscape. The event successfully equipped professionals with the knowledge and tools necessary to navigate the financial intricacies of the bioscience industry.
This eBook includes summaries of notable sessions from the Finance and Accounting for Bioscience Companies event as well as showcasing full sessions from key companies such as Condor Software, Crowe LLP, Breakaway Technologies, BDO, and Auxilius.
Click to read the eBook: Finance & Accounting for Bioscience Companies Post-Event Report
